Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prevalence-value-accuracy plots: a new method for comparing diagnostic tests based on misclassification costs.

A T Remaley1, M L Sampson, J M DeLeo

  • 1National Institutes of Health, Clinical Center, Clinical Pathology Department, Bethesda, MD 20892, USA. aremaley@nih.gov

Clinical Chemistry
|July 1, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

APOB to estimated APOB ratio for screening for the APOE2 genotype.

medRxiv : the preprint server for health sciences·2026
Same author

Effect of consumption of anthocyanin-rich products on NMR lipoprotein subclasses and biomarkers in hypercholesterolemic subjects: a randomized controlled trial (the AppleCOR study).

Food & function·2025
Same author

Klotho: a humeral mediator in CSF and plasma that influences longevity and susceptibility to multiple complex disorders, including depression.

Translational psychiatry·2016
Same author

Amphipathic polyproline peptides stimulate cholesterol efflux by the ABCA1 transporter.

Biochemical and biophysical research communications·2016
Same author

Lipoprotein Particles in Adolescents and Young Women With PCOS Provide Insights Into Their Cardiovascular Risk.

The Journal of clinical endocrinology and metabolism·2015
Same author

Measurement of low-density lipoprotein cholesterol in assessment and management of cardiovascular disease risk.

Clinical pharmacology and therapeutics·2014
Same journal

Interlaboratory Comparison of a Glucagon and Oxyntomodulin Immuno-LC-MS/MS Assay: Implications for Diabetes Research.

Clinical chemistry·2026
Same journal

Comparison of Information-Dependent Acquisition and Sequential Window Acquisition of All Theoretical Mass Spectra for Untargeted Drug Testing on a Linear Ion Trap-Pulsing Quadrupole-Time of Flight Mass Spectrometer.

Clinical chemistry·2026
Same journal

Patterns of One-Year Change in HbA1c and Continuous Glucose Monitoring (CGM) Metrics in Older Adults with Type 2 Diabetes.

Clinical chemistry·2026
Same journal

TSH Pediatric Reference Intervals: Lack of CALIPER Applicability to US-Based Populations.

Clinical chemistry·2026
Same journal

Rapid Detection of Hemoglobinopathy Variants Using One-Step Library Preparation and Nanopore Sequencing.

Clinical chemistry·2026
Same journal

Editor's Note: Circulating Proteolytic Products of Carboxypeptidase N for Early Detection of Breast Cancer.

Clinical chemistry·2026
See all related articles

This study introduces prevalence-value-accuracy (PVA) plots, a new graphical method for evaluating diagnostic tests. PVA plots enhance accuracy analysis by incorporating disease prevalence and misclassification costs for better clinical utility assessment.

Area of Science:

  • Medical diagnostics
  • Biostatistics
  • Health economics

Background:

  • Receiver Operating Characteristic (ROC) analysis is standard for diagnostic test accuracy.
  • ROC plots do not account for disease prevalence or the economic impact of test outcomes.
  • Practical diagnostic test utility depends on prevalence and misclassification costs.

Purpose of the Study:

  • To introduce a novel graphical method, Prevalence-Value-Accuracy (PVA) plot analysis.
  • To incorporate disease prevalence and misclassification costs into diagnostic test performance evaluation.
  • To provide a more comprehensive assessment of diagnostic test utility beyond traditional ROC analysis.

Main Methods:

  • Developed PVA plots as contour plots visualizing misclassification costs.

Related Experiment Videos

  • Defined the Unit Cost Ratio (UCR) to represent relative costs of false positives vs. false negatives.
  • Introduced a PVA-threshold plot for identifying optimal decision thresholds.

    • Main Results:

    • PVA plots display minimum misclassification costs across varying prevalence and UCR.
    • A quantitative index based on misclassification costs can be derived from PVA plots.
    • PVA analysis can yield different comparative interpretations than ROC area, especially within clinically relevant ranges.

    Conclusions:

    • PVA plot analysis directly integrates prevalence and misclassification costs.
    • It offers a quantitative index for comparing diagnostic tests based on cost-effectiveness.
    • PVA analysis facilitates identification of optimal decision thresholds tailored to specific clinical contexts.